Enhancement of Dendritic Cells as Vaccines for Cancer
Authors:
- 22 November 2010
- journal article
- review article
- Published by Taylor & Francis in Immunotherapy
- Vol. 2 (6) , 847-862
Abstract
Dendritic cells are the most potent antigen-presenting cells known; owing to their ability to stimulate antigen-specific cytolytic and memory T-cell responses, their use as cancer vaccines is rapidly increasing. While clinical trials provide evidence that dendritic cells vaccines are safe and elicit immunological responses in most patients, few complete tumor remissions have been reported and further technological advances are required. An effective dendritic cell vaccine must possess and maintain several characteristics: it must migrate to lymph nodes, have a mature, Th1-polarizing phenotype expressed stably after infusion and present antigen for sufficient time to produce a T-cell response capable of eliminating a tumor. While dendritic cells are readily matured ex vivo, their phenotype and fate after infusion are rarely evaluable; therefore, strategies to ensure that dendritic cells access lymphoid tissues and retain an immunostimulatory phenotype are required. In order to best exploit dendritic cells ...Keywords
This publication has 134 references indexed in Scilit:
- Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activityCancer Immunology, Immunotherapy, 2010
- The Dectin-2 family of C-type lectins in immunity and homeostasisCytokine, 2009
- Principles of Cancer Therapy: Oncogene and Non-oncogene AddictionCell, 2009
- Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligandEuropean Journal of Immunology, 2008
- A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell–mediated suppressionNature Medicine, 2008
- Engineered lentivector targeting of dendritic cells for in vivo immunizationNature Biotechnology, 2008
- Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell ResponsesImmunity, 2007
- Regulation of the lifespan in dendritic cell subsetsMolecular Immunology, 2007
- Pathogen Recognition and Innate ImmunityCell, 2006
- TREMs in the immune system and beyondNature Reviews Immunology, 2003